Semaglutide
FDA-approvedFDA-approved GLP-1 receptor agonist for type 2 diabetes and chronic weight management.
Avg. weight loss 12–15%
Dose range 0.25–2.4 mg
Cadence Weekly
Brands: Ozempic · Wegovy · Rybelsus
Full medication guide →GLP-1 Medications
Everything you need to know about each GLP-1 medication available through telehealth. Compare dosing, clinical trial results, side effects, and find out which providers carry each medication.
Tirzepatide
FDA-approvedDual GIP/GLP-1 receptor agonist with superior weight loss outcomes vs semaglutide.
Avg. weight loss 18–22%
Dose range 2.5–15 mg
Cadence Weekly
Brands: Mounjaro · Zepbound
Full medication guide →Retatrutide
Phase 3Triple agonist (GIP, GLP-1, glucagon) in Phase 3 trials — not yet FDA-approved.
Avg. weight loss ~24% (Ph2)
Dose range TBD
Cadence Weekly
Brands: Investigational (Eli Lilly)
Full medication guide →Compounded GLP-1
CompoundedCompounded versions available during FDA shortage via 503B-certified pharmacies.
Avg. weight loss Varies
Dose range Custom
Cadence Weekly
Brands: 503A/503B pharmacies
Full medication guide →